TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06069791

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bupivacaine Injection
Description: subcutaneous injection around bilateral greater occipital nerves

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bupivacaine Injection
Description: subcutaneous injection around bilateral greater occipital nerves

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bupivacaine Injection
Description: subcutaneous injection around bilateral greater occipital nerves

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bupivacaine Injection
Description: subcutaneous injection around bilateral greater occipital nerves
Study: NCT05207956

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioral economics strategies
Description: Behavioral economics features designed to increase motivation to collect data and ease of data collection on the electronic platform.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Electronic platform
Description: Electronic platform to collect data

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Electronic platform
Description: Electronic platform to collect data
Study: NCT05166148

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Session (a)
Description: Eccentric cycling

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Session (b)
Description: High intensity concentric cycling realized at the same mechanical power output than eccentric cycling

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Session (c)
Description: Low intensity concentric cycling realized at the same metabolic demand than eccentric cycling
Study: NCT06131086

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: stabilization exercises
Description: this include stabilization exercise thrice a week for six weeks

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: stabilization exercises along with pectoralis minor stretching
Description: this include stabilization exercise with pectoralis minor thrice a week for six weeks
Study: NCT05091645

Intervention type: OTHER
Intervention: GFI
Description: Two trained raters who will be blinded and will have no access to each other's evaluation, will administer the GFI questionnaire within 24 hours of patients' hospital admission.
Study: NCT05332535

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: serious game based web application education
Description: serious game based web application education for nursing students
Study: NCT04882150

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BMS-986196
Description: Specified dose on specified days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BMS-986196
Description: Specified dose on specified days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BMS-986196
Description: Specified dose on specified days

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Specified dose on specified days

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Specified dose on specified days
Study: NCT05855577

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Terazosin
Description: Treatment of Terazosine vs placebo and Lisosan-G vs placebo in cross-over double-blind, double-dummy

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Terazosin
Description: Treatment of Terazosine vs placebo and Lisosan-G vs placebo in cross-over double-blind, double-dummy

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Terazosin
Description: Treatment of Terazosine vs placebo and Lisosan-G vs placebo in cross-over double-blind, double-dummy

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Terazosin
Description: Treatment of Terazosine vs placebo and Lisosan-G vs placebo in cross-over double-blind, double-dummy
Study: NCT05271786

Intervention type: OTHER
Intervention: Decannulation
Description: retrospective evaluation of decannulation
Study: NCT05499572

Intervention type: DEVICE
Intervention: Inhalation maneuver with placebo Inbrija and placebo Cyclops
Description: Patients perform the inhalation maneuvers with placebo inhalers (Inbrija and Cyclops) during a Parkinson's off episode.

Intervention type: DEVICE
Intervention: Inhalation maneuver with placebo Inbrija and placebo Cyclops
Description: Patients perform the inhalation maneuvers with placebo inhalers (Inbrija and Cyclops) during a Parkinson's off episode.
Study: NCT04767477

Intervention type: OTHER
Group type: OTHER
Intervention: Face-to-face rehabilitation
Description: Aerobic training will be performed with 60% to 80% of the maximum VO2 obtained through the CPET. The exercise will be performed on the treadmill, with a total time of 40 minutes, with 5 minutes of warm-up, 30 minutes of conditioning, 5 minutes of cooling down. Resistance training will be performed for upper and lower limbs and the load used in the exercises will be 60% of the maximum repetition test (1RM), with load progression every six sessions. The exercises are performed in three series of 12 repetitions.

Intervention type: OTHER
Group type: OTHER
Intervention: Telerehabilitation
Description: The telerehabilitation protocol will consist of stretching the muscles of the upper and lower limbs and accessory muscles of breathing. The conditioning phase will consist of stationary walking, side running, jumping jump and stationary running, 3 times of 40 seconds with a 30-second passive rest interval between them. Resistance training will be applied to the muscles of the upper limbs and lower limbs, with specific exercises for each musculature, using elastic bands as resistance.
Study: NCT04306107

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Prone position during non-invasive respiratory support
Description: HFNC and NIV application with patient on prone position

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Prone position during non-invasive respiratory support
Description: HFNC and NIV application with patient on prone position

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Prone position during non-invasive respiratory support
Description: HFNC and NIV application with patient on prone position

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Prone position during non-invasive respiratory support
Description: HFNC and NIV application with patient on prone position
Study: NCT06322420

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioural Activation (BA)
Description: Behavioural activation treatment delivered in this single arm study. Individual treatment given to all participants in 12 sessions over 11 weeks. All treatment components have been introduced by session 8 that defines minimum amount of treatment in the trial (i.e. 8 session completed).~Behavioral Activation is a psychological treatment for depression focused on gradually re-engaging people with sources of reinforcement and reward in their environment by re-establish healthy patterns of activity, and replace avoidance behaviours with more adaptive behaviours.
Study: NCT06176326

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ethics Education Program in Nursing
Description: In the 7-session training program, each session, lasting 2 hours, presented to students the topic headings determined through the needs analysis of the program development study. This education program consists of sessions on the Introduction to Ethics-Bioethics, Principles of Beneficence and Non-maleficence, Autonomy and Responsibility, Informed Consent and Those Lacking Capacity for Consent, Respect for Human Vulnerability and Individual Integrity, Respect for Private Life and Ensuring Confidentiality, Discrimination, Stigmatization, and Cultural Diversity.
Study: NCT05123222

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: ZIKV-SJRP/2016-184 Strain
Description: Zika Virus Strain

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Experimental: ZIKV-Nicaragua/2016 Strain
Description: Zika Virus Strain

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Not an active strain of Zika
Study: NCT05493514

Intervention type: DEVICE
Intervention: Robotic Assisted Gait Training with G-EO system
Description: Robotic-assisted gait training is a rehabilitation treatment that applies robotic technologies to improve mobility of patients with stroke or other neurological disorders. In this study, participants will use the G-EO system robotic device according to the daily clinical practice of the Don Gnocchi Foundation.
Study: NCT05381350

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: COVID-19 Vaccine (Vero cell), Inactivated (Omicron variant)
Description: The COVID-19 Vaccine (Vero cell), Inactivated (Omicron variant)was manufactured by Sinovac Research\& Development Co., Ltd.1200SOU inactivated SARS-CoV-2 Omicron strain in 0.5ml of aluminium hydroxide solution per injection.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: COVID-19 Vaccine (Vero cell), Inactivated (Omicron variant)
Description: The COVID-19 Vaccine (Vero cell), Inactivated (Omicron variant)was manufactured by Sinovac Research\& Development Co., Ltd.1200SOU inactivated SARS-CoV-2 Omicron strain in 0.5ml of aluminium hydroxide solution per injection.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: COVID-19 Vaccine (Vero cell), Inactivated (Omicron variant)
Description: The COVID-19 Vaccine (Vero cell), Inactivated (Omicron variant)was manufactured by Sinovac Research\& Development Co., Ltd.1200SOU inactivated SARS-CoV-2 Omicron strain in 0.5ml of aluminium hydroxide solution per injection.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: COVID-19 Vaccine (Vero cell), Inactivated (Omicron variant)
Description: The COVID-19 Vaccine (Vero cell), Inactivated (Omicron variant)was manufactured by Sinovac Research\& Development Co., Ltd.1200SOU inactivated SARS-CoV-2 Omicron strain in 0.5ml of aluminium hydroxide solution per injection.

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: COVID-19 Vaccine (Vero cell), Inactivated (CZ strain)
Description: The COVID-19 vaccine,inactivated was manufactured by Sinovac Research\& Development Co., Ltd.600SU inactivated SARS-CoV-2 CZ strain virus in 0.5 mL of aluminium hydroxide solution per injection.

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: COVID-19 Vaccine (Vero cell), Inactivated (CZ strain)
Description: The COVID-19 vaccine,inactivated was manufactured by Sinovac Research\& Development Co., Ltd.600SU inactivated SARS-CoV-2 CZ strain virus in 0.5 mL of aluminium hydroxide solution per injection.

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: COVID-19 Vaccine (Vero cell), Inactivated (CZ strain)
Description: The COVID-19 vaccine,inactivated was manufactured by Sinovac Research\& Development Co., Ltd.600SU inactivated SARS-CoV-2 CZ strain virus in 0.5 mL of aluminium hydroxide solution per injection.

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: COVID-19 Vaccine (Vero cell), Inactivated (CZ strain)
Description: The COVID-19 vaccine,inactivated was manufactured by Sinovac Research\& Development Co., Ltd.600SU inactivated SARS-CoV-2 CZ strain virus in 0.5 mL of aluminium hydroxide solution per injection.

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: COVID-19 Vaccine (Vero cell), Inactivated (CZ strain)
Description: The COVID-19 vaccine,inactivated was manufactured by Sinovac Research\& Development Co., Ltd.600SU inactivated SARS-CoV-2 CZ strain virus in 0.5 mL of aluminium hydroxide solution per injection.
Study: NCT04948931

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Lavender aromatherapy
Description: The application will be once a day, every day for four weeks. Each session will take five minutes.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Rosemary aromatherapy
Description: The application will be once a day, every day for four weeks. Each session will take five minutes.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Control
Description: The application will be once a day, every day for four weeks. Each session will take five minutes.
Study: NCT05517278

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: SurgX Antimicrobial Wound Gel
Description: In addition to standard of care, at time of surgery, SurgX applied on the incision after closure and then re-applied at the time of first bandage change on day of discharge.

Intervention type: OTHER
Group type: OTHER
Intervention: Standard of Care
Description: The control group will receive standard of care.
Study: NCT05527548

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Alendronate (ALN)
Description: The oral ALN is the first-line therapy for osteoporosis, and it has been proven that once-weekly ALN 70 mg is an effective and well-tolerated dose for the treatment of postmenopausal osteoporosis. In this study, after receiving the approval of CREC and the Department of Health, we will purchase ALN from drug store. Previous clinical studies have shown that oral administration of ALN at 70mg/week for 1 year and at 5mg/day for 2 years reduced bone loss in postmenopausal women and patients who underwent total hip arthroplasty, respectively. Therefore, in the proposed study, ALN at the dose of 70mg/week will be given to patients post-ACLR for a duration of 8 weeks.
Study: NCT05494671

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: conjunctival limbal autologous transplant
Description: Patients with unilateral chemical ocular injury will be included in the study. All selected patients will receive a thorough explanation of the study design and aims and informed consent will be obtained in all patients. Eyes of all participants will be subjected to: Best corrected visual acuity, Slit lamp examination and ocular ultrasound if no fundus view.~Staging of degree of limbal stem cell deficiency is done by Roper Hall classification and then the patient will have conjunctival limbal autologous transplant (CLAU)
Study: NCT05001022

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ALG-020572
Description: Single or multiple doses of ALG-020572

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Single or multiple doses of Placebo
Study: NCT05000658

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone phosphate
Description: HSC injection of 4mL

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Dexamethasone phosphate
Description: HSC injection of 4mL
Study: NCT05571189

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Daily Activity Text
Description: Participants will receive a text each day with instructions about the daily activity they should complete for that day.

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Control Text
Description: Participants will receive a text each day with no instructions about daily activity. It will have messages like have a nice day.
Study: NCT04960722

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: OIF/β-TCP
Description: bone graft implantation

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: OIF/β-TCP
Description: bone graft implantation

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: OIF/β-TCP
Description: bone graft implantation

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: OIF/β-TCP
Description: bone graft implantation
Study: NCT05417230

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RC48-ADC
Description: 2.5mg/kg, IV, d1, every 2 weeks;

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Envafolimab
Description: 200mg, SC, d1, every 2 weeks;
Study: NCT05133817

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Normal saline
Description: Simultaneous with spinal anesthesia, 500 mL 6% Hydroxyethyl starch (130/0.4) coload was given and a maintenance dose of normal saline by IV infusion.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Norepinephrine (0.025 μg/kg/min)
Description: Simultaneous with spinal anesthesia, 500 mL 6% Hydroxyethyl starch (130/0.4) coload was given and a different maintenance dose of norepinephrine by IV infusion.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Norepinephrine (0.05 μg/kg/min)
Description: Simultaneous with spinal anesthesia, 500 mL 6% Hydroxyethyl starch (130/0.4) coload was given and a different maintenance dose of norepinephrine by IV infusion.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Norepinephrine (0.075 μg/kg/min)
Description: Simultaneous with spinal anesthesia, 500 mL 6% Hydroxyethyl starch (130/0.4) coload was given and a different maintenance dose of norepinephrine by IV infusion.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Norepinephrine (0.1 μg/kg/min)
Description: Simultaneous with spinal anesthesia, 500 mL 6% Hydroxyethyl starch (130/0.4) coload was given and a different maintenance dose of norepinephrine by IV infusion.
Study: NCT05595590

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tislelizumab
Description: Administered as an intravenous (IV) infusion 200mg every 3 weeks (Q3W)

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Pulse radiation
Description: 66-70Gy/33-35Fx, 2Gy/Fx.
Study: NCT05462379

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Ovarian graft
Description: Before the beginning of pelvic radiotherapy, one of the ovaries will be removed by laparoscopy. Ovary slices of 1-2 mm will be prepared in sterile environment and engrafted in the fatty tissue of inner tight. One representative fragment will undergo histologic evaluation. These procedures will be done in the same surgical time.
Study: NCT05207475

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Remote ischemic conditioning
Description: RIC is a non-invasive therapy that performed by an electric auto-control device with cuff placed on arm. RIC procedures consist of five cycles of 5-min inflation (200 mmHg) and 5-min deflation of cuff on one arm. The procedure will be performed twice daily for consecutive 1 years after enrollment.
Study: NCT04736823

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AK112
Description: IV infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AK112
Description: IV infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AK112
Description: IV infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AK112
Description: IV infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AK112
Description: IV infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AK112
Description: IV infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pemetrexed
Description: IV infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pemetrexed
Description: IV infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pemetrexed
Description: IV infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel
Description: IV infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel
Description: IV infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: IV infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: IV infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: IV infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Docetaxel
Description: IV infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Docetaxel
Description: IV infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Docetaxel
Description: IV infusion
Study: NCT06644989

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Spencer Technique
Description: Spencer technique on the hip

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham (No Treatment)
Description: Spencer technique position but no pressure
Study: NCT05345470

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: 140 calories per 30 gram test meal
Description: Food

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 140 calories per 30 gram test meal
Description: Food
Study: NCT04829045

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SEIRIN PYONEX Acupuncture Needles
Description: 10 press needles (PYONEX ø0.20×1.5mm made by Seirin Corporation) will be placed on abdomen area; 10 sessions over 6 weeks.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: PYONEX Placebo
Description: Subjects are given placebo on abdomen area; 10 sessions over 6 weeks.
Study: NCT04492553

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AndroGel
Description: Treatment indication: hypogonadism after cancer treatment. Dosage: 1-2 sachets a day. Follows standard treatment.
Study: NCT05345470

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 140 calories per 30 gram test meal
Description: Food

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 140 calories per 30 gram test meal
Description: Food
Study: NCT02747914

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial magnetic stimulation
Description: TMS 1Hz under the motor zone of cortex.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional exercise
Description: Exercise will be administrated in a conventional way.
Study: NCT06129630

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional occupational therapy sessions.
Description: Occupational therapy sessions are based on cognitive stimulation, manipulative dexterity training and psychomotor skills.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Conventional occupational therapy sessions + Nintendo Switch
Description: Occupational therapy sessions are based on cognitive stimulation, manipulative skill training and psychomotor skills. In addition, 2 sessions per week are conducted with two Nintendo Switch games.
Study: NCT05824325

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR-A1811
Description: HER2 ADC

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TROP2 ADC
Description: TROP2 ADC
Study: NCT04828824

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ethinyl Estradiol / Norgestimate Oral Tablet
Description: Those who desire COCs as an intervention are prescribed (over the phone) or given (in person) 3 packs of COCs. They are told to take one pill per day until the first pack is complete and save the remaining 2 packs for possible future use.
Study: NCT05669742

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Empagliflozin
Description: sodium-glucose transport protein two inhibitor

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: olanzapine
Description: antipsychotics
Study: NCT04739839

Intervention type: OTHER
Intervention: survey questionnaire
Description: Questionnaire focusing on low back pain in relation to life style, physical activity level, illness perception and quality of life.